Given the exquisite dependency of Ewing sarcoma on EWS::ETS driver fusions, pharmacologic approaches to inhibit their expression or activity have long been sought and several candidate drugs have been identified (Table 2). Here, EWSR1 is linked to Ewing sarcoma.